We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACDC icon
3251
ProFrac Holding
ACDC
$958M
$282K ﹤0.01%
+11,200
New +$247K
DNA icon
3252
Ginkgo Bioworks
DNA
$488M
$282K ﹤0.01%
4,167
-312
-7% -$28.7K
FELE icon
3253
Franklin Electric
FELE
$4.68B
$281K ﹤0.01%
3,528
+439
+14% +$36.2K
FISI icon
3254
Financial Institutions
FISI
$825M
$281K ﹤0.01%
11,544
-264
-2% -$6.49K
EMDV icon
3255
ProShares MSCI Emerging Markets Dividend Growers ETF
EMDV
$7.39M
$280K ﹤0.01%
6,192
-1,637
-21% -$71.8K
WOOD icon
3256
iShares Global Timber & Forestry ETF
WOOD
$269M
$280K ﹤0.01%
3,846
-2,222
-37% -$161K
WOW
3257
DELISTED
WideOpenWest
WOW
$279K ﹤0.01%
30,653
+2,122
+7% +$24K
ESTA icon
3258
Establishment Labs
ESTA
$2.25B
$279K ﹤0.01%
4,250
-93
-2% -$5.62K
DCH
3259
Dauch Corp
DCH
$1.6B
$279K ﹤0.01%
35,675
+17,228
+93% +$154K
NPFD icon
3260
Nuveen Variable Rate Preferred & Income Fund
NPFD
$454M
$278K ﹤0.01%
15,816
+856
+6% +$14.9K
VHI icon
3261
Valhi
VHI
$466M
$277K ﹤0.01%
12,605
+2,700
+27% +$65.6K
DAN icon
3262
Dana Inc
DAN
$3.26B
$277K ﹤0.01%
18,303
-2,574
-12% -$39.9K
AIVI icon
3263
WisdomTree International AI Enhanced Value Fund
AIVI
$63.4M
$277K ﹤0.01%
7,661
+351
+5% +$12K
RLJ icon
3264
RLJ Lodging Trust
RLJ
$1.67B
$277K ﹤0.01%
+26,115
New +$296K
GPMT
3265
Granite Point Mortgage Trust
GPMT
$58.8M
$276K ﹤0.01%
51,553
-33,506
-39% -$218K
ALEX
3266
DELISTED
Alexander & Baldwin
ALEX
$276K ﹤0.01%
+14,751
New +$279K
DNLI icon
3267
Denali Therapeutics
DNLI
$3.97B
$276K ﹤0.01%
+9,917
New +$295K
PMX
3268
DELISTED
PIMCO Municipal Income Fund III
PMX
$275K ﹤0.01%
31,624
+20,364
+181% +$175K
DVYE icon
3269
iShares Emerging Markets Dividend ETF
DVYE
$1.21B
$275K ﹤0.01%
11,411
+824
+8% +$19.7K
PRAX icon
3270
Praxis Precision Medicines
PRAX
$10.3B
$275K ﹤0.01%
7,703
-133
-2% -$4.15K
XRN
3271
Chiron Real Estate Inc
XRN
$484M
$274K ﹤0.01%
5,778
-16,245
-74% -$735K
XFLT
3272
XAI Floating Rate & Alternative Income Trust
XFLT
$294M
$274K ﹤0.01%
8,660
-1,172
-12% -$37.3K
QTUM icon
3273
Defiance Quantum ETF
QTUM
$5.82B
$273K ﹤0.01%
6,977
-417
-6% -$16.2K
AFRM icon
3274
Affirm
AFRM
$26.2B
$273K ﹤0.01%
28,196
-8,641
-23% -$130K
CMP icon
3275
Compass Minerals
CMP
$1.1B
$273K ﹤0.01%
6,650
-1,459
-18% -$60.3K

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.